{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:15:38Z","timestamp":1794694538331,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390740016"],"award-info":[{"award-number":["390740016"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MO 3226\/4-1"],"award-info":[{"award-number":["MO 3226\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["471011418"],"award-info":[{"award-number":["471011418"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["471011418"],"award-info":[{"award-number":["471011418"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST 95\/1650-1 FUGG"],"award-info":[{"award-number":["INST 95\/1650-1 FUGG"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR353\/1 \u2013 471011418"],"award-info":[{"award-number":["TRR353\/1 \u2013 471011418"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ferroptosis and apoptosis are widely considered to be independent cell death modalities. Ferroptotic cell death is a consequence of insufficient radical detoxification and progressive lipid peroxidation, which is counteracted by glutathione peroxidase-4 (GPX4). Apoptotic cell death can be triggered by a wide variety of stresses, including oxygen radicals, and can be suppressed by anti-apoptotic members of the BCL-2 protein family. Mitochondria are the main interaction site of BCL-2 family members and likewise a major source of oxygen radical stress. We therefore studied if ferroptosis and apoptosis might intersect and possibly interfere with one another. Indeed, cells dying from impaired GPX4 activity displayed hallmarks of both ferroptotic and apoptotic cell death, with the latter including (transient) membrane blebbing, submaximal cytochrome-c release and caspase activation. Targeting BCL-2, MCL-1 or BCL-XL with BH3-mimetics under conditions of moderate ferroptotic stress in many cases synergistically enhanced overall cell death and frequently skewed primarily ferroptotic into apoptotic outcomes. Surprisingly though, in other cases BH3-mimetics, most notably the BCL-XL inhibitor WEHI-539, counter-intuitively suppressed cell death and promoted cell survival following GPX4 inhibition. Further studies revealed that most BH3-mimetics possess previously undescribed antioxidant activities that counteract ferroptotic cell death at commonly employed concentration ranges. Our results therefore show that ferroptosis and apoptosis can intersect. We also show that combining ferroptotic stress with BH3-mimetics, context-dependently can either enhance and convert cell death outcomes between ferroptosis and apoptosis or can also suppress cell death by intrinsic antioxidant activities.<\/jats:p>","DOI":"10.1038\/s41418-025-01514-7","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:09:55Z","timestamp":1745899795000},"page":"1970-1985","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Interplay of ferroptotic and apoptotic cell death and its modulation by BH3-mimetics"],"prefix":"10.1038","volume":"32","author":[{"given":"Yun","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana A.","family":"H\u00fcther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Wank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Tykwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maceler","family":"Aldrovandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Henkelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4332-1280","authenticated-orcid":false,"given":"Julia","family":"Mergner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Laschat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1140-5612","authenticated-orcid":false,"given":"Marcus","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6731-8707","authenticated-orcid":false,"given":"Daniela","family":"St\u00f6hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6149-9261","authenticated-orcid":false,"given":"Markus","family":"Rehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"1514_CR1","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","volume":"1830","author":"SC Lu","year":"2013","unstructured":"Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830:3143\u201353.","journal-title":"Biochim Biophys Acta"},{"key":"1514_CR2","doi-asserted-by":"publisher","first-page":"22244","DOI":"10.1074\/jbc.M110.121327","volume":"285","author":"PK Mandal","year":"2010","unstructured":"Mandal PK, Seiler A, Perisic T, Kolle P, Banjac Canak A, Forster H, et al. System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency. J Biol Chem. 2010;285:22244\u201353.","journal-title":"J Biol Chem"},{"key":"1514_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0021-9258(18)70932-0","volume":"214","author":"H Eagle","year":"1955","unstructured":"Eagle H. The specific amino acid requirements of a mammalian cell (strain L) in tissue culture. J Biol Chem. 1955;214:839\u201352.","journal-title":"J Biol Chem"},{"key":"1514_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 2008;15:234\u201345.","journal-title":"Chem Biol"},{"key":"1514_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285\u201396.","journal-title":"Cancer Cell"},{"key":"1514_CR6","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife 2014;3:e02523.","journal-title":"eLife"},{"key":"1514_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331.","journal-title":"Cell"},{"key":"1514_CR8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cub.2023.02.060","volume":"33","author":"Y Hirata","year":"2023","unstructured":"Hirata Y, Cai R, Volchuk A, Steinberg BE, Saito Y, Matsuzawa A, et al. Lipid peroxidation increases membrane tension, Piezo1 gating, and cation permeability to execute ferroptosis. Curr Biol. 2023;33:1282\u201394.e5.","journal-title":"Curr Biol"},{"key":"1514_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41419-023-06284-z","volume":"14","author":"Y Dondelinger","year":"2023","unstructured":"Dondelinger Y, Priem D, Huyghe J, Delanghe T, Vandenabeele P, Bertrand MJM. NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis. Cell death Dis. 2023;14:755.","journal-title":"Cell death Dis"},{"key":"1514_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"JF Kerr","year":"1972","unstructured":"Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239\u201357.","journal-title":"Br J Cancer"},{"key":"1514_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","volume":"24","author":"PE Czabotar","year":"2023","unstructured":"Czabotar PE, Garcia-Saez AJ. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat Rev Mol Cell Biol. 2023;24:732\u201348.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1514_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","volume":"22","author":"ST Diepstraten","year":"2022","unstructured":"Diepstraten ST, Anderson MA, Czabotar PE, Lessene G, Strasser A, Kelly GL. The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs. Nat Rev Cancer. 2022;22:45\u201364.","journal-title":"Nat Rev Cancer"},{"key":"1514_CR13","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863:2977\u201392.","journal-title":"Biochim Biophys Acta"},{"key":"1514_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","volume":"8","author":"A Seiler","year":"2008","unstructured":"Seiler A, Schneider M, Forster H, Roth S, Wirth EK, Culmsee C, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8:237\u201348.","journal-title":"Cell Metab"},{"key":"1514_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138.","journal-title":"Nature"},{"key":"1514_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41587-019-0037-y","volume":"37","author":"Y Liu","year":"2019","unstructured":"Liu Y, Mi Y, Mueller T, Kreibich S, Williams EG, Van Drogen A, et al. Multi-omic measurements of heterogeneity in HeLa cells across laboratories. Nat Biotechnol. 2019;37:314\u201322.","journal-title":"Nat Biotechnol"},{"key":"1514_CR17","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1038\/s41418-020-0559-3","volume":"27","author":"D St\u00f6hr","year":"2020","unstructured":"St\u00f6hr D, Schmid JO, Beigl TB, Mack A, Maichl DS, Cao K, et al. Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids. Cell Death Differ. 2020;27:3037\u201352.","journal-title":"Cell Death Differ"},{"key":"1514_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497\u2013509.","journal-title":"J Biol Chem"},{"key":"1514_CR19","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1021\/acs.analchem.0c04565","volume":"93","author":"L Gao","year":"2021","unstructured":"Gao L, Ji S, Burla B, Wenk MR, Torta F, Cazenave-Gassiot A. LICAR: an application for isotopic correction of targeted lipidomic data acquired with class-based chromatographic separations using multiple reaction monitoring. Anal Chem. 2021;93:3163\u201371.","journal-title":"Anal Chem"},{"key":"1514_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15363-z","volume":"7","author":"Z Ni","year":"2017","unstructured":"Ni Z, Angelidou G, Hoffmann R, Fedorova M. LPPtiger software for lipidome-specific prediction and identification of oxidized phospholipids from LC-MS datasets. Sci Rep. 2017;7:15138.","journal-title":"Sci Rep"},{"key":"1514_CR21","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima E, Ito J, Wu Z, Nakamura T, Wahida A, Doll S, et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022;608:778\u201383.","journal-title":"Nature"},{"key":"1514_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling DR, Swain-Bowden MJ, Lucas AM, Carpenter AE, Cimini BA, Goodman A. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinforma. 2021;22:433.","journal-title":"BMC Bioinforma"},{"key":"1514_CR23","doi-asserted-by":"crossref","unstructured":"Webb JL. Enzyme and metabolic inhibitors. New York: Academic Press; 1963.","DOI":"10.5962\/bhl.title.7320"},{"key":"1514_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.4103\/1673-5374.266060","volume":"15","author":"J Chu","year":"2020","unstructured":"Chu J, Liu CX, Song R, Li QL. Ferrostatin-1 protects HT-22 cells from oxidative toxicity. Neural Regen Res. 2020;15:528\u201336.","journal-title":"Neural Regen Res"},{"key":"1514_CR25","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.redox.2017.03.007","volume":"12","author":"S Neitemeier","year":"2017","unstructured":"Neitemeier S, Jelinek A, Laino V, Hoffmann L, Eisenbach I, Eying R, et al. BID links ferroptosis to mitochondrial cell death pathways. Redox Biol. 2017;12:558\u201370.","journal-title":"Redox Biol"},{"key":"1514_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101328","volume":"28","author":"G Miotto","year":"2020","unstructured":"Miotto G, Rossetto M, Di Paolo ML, Orian L, Venerando R, Roveri A, et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol. 2020;28:101328.","journal-title":"Redox Biol"},{"key":"1514_CR27","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1016\/j.febslet.2010.10.046","volume":"584","author":"MT Silva","year":"2010","unstructured":"Silva MT. Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett. 2010;584:4491\u20139.","journal-title":"FEBS Lett"},{"key":"1514_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09753-2","volume":"10","author":"K Tsuchiya","year":"2019","unstructured":"Tsuchiya K, Nakajima S, Hosojima S, Thi Nguyen D, Hattori T, Manh Le T, et al. Caspase-1 initiates apoptosis in the absence of gasdermin D. Nat Commun. 2019;10:2091.","journal-title":"Nat Commun"},{"key":"1514_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153\u20138.","journal-title":"Nature"},{"key":"1514_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187:235\u201356.","journal-title":"Cell"},{"key":"1514_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2024;25:379\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1514_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chom.2018.05.009","volume":"24","author":"R Kang","year":"2018","unstructured":"Kang R, Zeng L, Zhu S, Xie Y, Liu J, Wen Q, et al. Lipid peroxidation drives gasdermin D-mediated pyroptosis in lethal polymicrobial sepsis. Cell Host Microbe. 2018;24:97\u2013108.e4.","journal-title":"Cell Host Microbe"},{"key":"1514_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49067-6","volume":"15","author":"S Dadsena","year":"2024","unstructured":"Dadsena S, Cuevas Arenas R, Vieira G, Brodesser S, Melo MN, Garcia-Saez AJ. Lipid unsaturation promotes BAX and BAK pore activity during apoptosis. Nat Commun. 2024;15:4700.","journal-title":"Nat Commun"},{"key":"1514_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0925-4439(95)00011-R","volume":"1271","author":"SJ Korsmeyer","year":"1995","unstructured":"Korsmeyer SJ, Yin XM, Oltvai ZN, Veis-Novack DJ, Linette GP. Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim Biophys Acta. 1995;1271:63\u20136.","journal-title":"Biochim Biophys Acta"},{"key":"1514_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/bj3510183","volume":"351","author":"K Nomura","year":"2000","unstructured":"Nomura K, Imai H, Koumura T, Kobayashi T, Nakagawa Y. Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis. Biochem J. 2000;351:183\u201393.","journal-title":"Biochem J"},{"key":"1514_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/35004029","volume":"2","author":"JC Goldstein","year":"2000","unstructured":"Goldstein JC, Waterhouse NJ, Juin P, Evan GI, Green DR. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol. 2000;2:156\u201362.","journal-title":"Nat Cell Biol"},{"key":"1514_CR37","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1038\/sj.emboj.7601295","volume":"25","author":"M Rehm","year":"2006","unstructured":"Rehm M, Huber HJ, Dussmann H, Prehn JH. Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. Embo J. 2006;25:4338\u201349.","journal-title":"Embo J"},{"key":"1514_CR38","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.molcel.2015.01.018","volume":"57","author":"G Ichim","year":"2015","unstructured":"Ichim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, Delgado ME, et al. Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol Cell. 2015;57:860\u201372.","journal-title":"Mol Cell"},{"key":"1514_CR39","doi-asserted-by":"crossref","unstructured":"Pollak N, Lindner A, Imig D, Kuritz K, Fritze JS, Decker L, et al. Cell cycle progression and transmitotic apoptosis resistance promote escape from extrinsic apoptosis. J Cell Sci. 2021;134:jcs258966.","DOI":"10.1242\/jcs.258966"},{"key":"1514_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01212-22","volume":"96","author":"S Gradzka-Boberda","year":"2022","unstructured":"Gradzka-Boberda S, Gentle IE, Hacker G. Pattern recognition receptors of nucleic acids can cause sublethal activation of the mitochondrial apoptosis pathway during viral infection. J Virol. 2022;96:e0121222.","journal-title":"J Virol"},{"key":"1514_CR41","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cmet.2019.01.011","volume":"29","author":"KH Lin","year":"2019","unstructured":"Lin KH, Xie A, Rutter JC, Ahn YR, Lloyd-Cowden JM, Nichols AG, et al. Systematic dissection of the metabolic-apoptotic interface in AML reveals heme biosynthesis to be a regulator of drug sensitivity. Cell Metab. 2019;29:1217\u201331.e7.","journal-title":"Cell Metab"},{"key":"1514_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137.","journal-title":"Nature"},{"key":"1514_CR43","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551:247\u201350.","journal-title":"Nature"},{"key":"1514_CR44","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.cell.2022.07.025","volume":"185","author":"H Kalkavan","year":"2022","unstructured":"Kalkavan H, Chen MJ, Crawford JC, Quarato G, Fitzgerald P, Tait SWG, et al. Sublethal cytochrome c release generates drug-tolerant persister cells. Cell. 2022;185:3356\u201374.e22.","journal-title":"Cell"},{"key":"1514_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41589-021-00751-4","volume":"17","author":"M Conlon","year":"2021","unstructured":"Conlon M, Poltorack CD, Forcina GC, Armenta DA, Mallais M, Perez MA, et al. A compendium of kinetic modulatory profiles identifies ferroptosis regulators. Nat Chem Biol. 2021;17:665\u201374.","journal-title":"Nat Chem Biol"},{"key":"1514_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41420-024-01800-2","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, Wang Y, Tan J, Li Y, Yang P, Liu X, et al. Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell Death Discov. 2024;10:35.","journal-title":"Cell Death Discov"},{"key":"1514_CR47","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41419-020-02867-2","volume":"11","author":"A Roca-Portoles","year":"2020","unstructured":"Roca-Portoles A, Rodriguez-Blanco G, Sumpton D, Cloix C, Mullin M, Mackay GM, et al. Venetoclax causes metabolic reprogramming independent of BCL-2 inhibition. Cell death Dis. 2020;11:616.","journal-title":"Cell death Dis"},{"key":"1514_CR48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1515\/hsz-2022-0321","volume":"404","author":"C Barisch","year":"2023","unstructured":"Barisch C, Holthuis JCM, Cosentino K. Membrane damage and repair: a thin line between life and death. Biol Chem. 2023;404:467\u201390.","journal-title":"Biol Chem"},{"key":"1514_CR49","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41556-024-01364-4","volume":"26","author":"AJ Mathiowetz","year":"2024","unstructured":"Mathiowetz AJ, Olzmann JA. Lipid droplets and cellular lipid flux. Nat Cell Biol. 2024;26:331\u201345.","journal-title":"Nat Cell Biol"},{"key":"1514_CR50","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.1206727","volume":"334","author":"T Ni Chonghaile","year":"2011","unstructured":"Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, Moore Vdel G, et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science. 2011;334:1129\u201333.","journal-title":"Science"},{"key":"1514_CR51","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1021\/ml5001867","volume":"5","author":"ZF Tao","year":"2014","unstructured":"Tao ZF, Hasvold L, Wang L, Wang X, Petros AM, Park CH, et al. Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity. ACS Med Chem Lett. 2014;5:1088\u201393.","journal-title":"ACS Med Chem Lett"},{"key":"1514_CR52","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","volume":"11","author":"WH Wilson","year":"2010","unstructured":"Wilson WH, O\u2019Connor OA, Czuczman MS, LaCasce AS, Gerecitano JF, Leonard JP, et al. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 2010;11:1149\u201359.","journal-title":"Lancet Oncol"},{"key":"1514_CR53","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s43856-023-00380-z","volume":"3","author":"J Yuda","year":"2023","unstructured":"Yuda J, Will C, Phillips DC, Abraham L, Alvey C, Avigdor A, et al. Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients. Commun Med (Lond). 2023;3:154.","journal-title":"Commun Med (Lond)"},{"key":"1514_CR54","doi-asserted-by":"crossref","unstructured":"Yang X, Mei C, He X, He L, Lu X, Tong H, et al. Quantification of venetoclax for therapeutic drug monitoring in chinese acute myeloid leukemia patients by a validated UPLC-MS\/MS Method. Molecules. 2022;27:1607.","DOI":"10.3390\/molecules27051607"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01514-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01514-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01514-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:52:50Z","timestamp":1761735170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01514-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1514"],"URL":"https:\/\/doi.org\/10.1038\/s41418-025-01514-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.04.611207","asserted-by":"object"}]},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MC is a co-founder and shareholder of ROSCUE Therapeutics GmbH and holds patents on compounds modulating ferroptosis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All work was conducted in commercially available cell lines. Ethics approval was not required for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}